A randomized, open-labeled, prospective controlled study to assess the efficacy of frontline empirical intravenous piperacillin/tazobactam monotherapy in comparison with ceftazidime plus amikacin for febrile neutropenia in pediatric oncology patients

• Main Authors: Ruchirek Kamonrattana, Lalita Sathitsamitphong, Worawut Choeyprasert, Pimlak Charoenkwan, Rungrote Natesirinilkul, Kanda Fanhchaksai
• 格式: 雜誌
• 出版: 2020
• 主題: Biochemistry, Genetics and Molecular Biology; Medicine
• 在線閱讀: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85072655299&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/67628

© 2019 Asian Pacific Organization for Cancer Prevention. Background: Febrile neutropenia (FN) is the most common complication in pediatric oncology patients. Appropriate empirical antibiotics treatment is essential for treatment outcome. Methods: This study was a randomized prospective controlled st...